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1. Introduction 
The electrocardiogram (ECG) is a simple test that detects and records the electrical activity 
of the heart that is externally recorded by skin electrodes. It is a noninvasive recording 
produced by an electrocardiographic device. The etymology of the word is derived from the 
Greek electro, because it is related to electrical activity, cardio, Greek for heart, and graph, a 
Greek root meaning "to write".It is used to detect and locate the source of heart problems.  
The electric activity of the heart is produced by the depolarization and repolarization of the 
cardiac cells and in each heart beat a healthy heart will have an orderly progression of a 
wave of depolarization that is triggered by the cells in the sinoatrial node, spreads out 
through the atrium, passes through intrinsic conduction pathways and then spreads all over 
the ventricles. This electric activity will be responsible of an ordered contraction first of the 
atria and then of the ventricles. 
 The recording of an electrocardiogram is using usually more than 2 electrodes that can be 
combined into a number of pairs ( Left arm (LA), right arm (RA) and left leg (LL) electrodes 
form the pairs: LA+RA, LA+LL, RA+LL). The output from each pair is known as a lead. 
Each lead registers the electric activity of the heart from a different angle. 
The electrocardiogram is one of the best and easy way to measure and diagnose abnormal 
rhythms of the heart, particularly abnormal rhythms caused by damage to the conductive 
tissue that carries electrical signals, or abnormal rhythms caused by electrolyte imbalances. 
In a myocardial infarction , the ECG can identify if the heart muscle has been damaged in 
specific areas, though not all areas of the heart are covered. The ECG cannot reliably 
measure the pumping ability of the heart, for which ultrasound-based (echocardiography) 
or nuclear medicine tests are used. 
Heart failure is a highly prevalent chronic disease that results in varying degrees of 
functional alteration. One of the most important determinants of congestive heart failure 
and sudden death in Latin America is Chagas disease provoked by the infection with the 
intracellular protozoan Trypanosoma cruzi. It affects approximately 20 million people (WHO 
2007; Moncayo and Silveira 2009) and represents a serious public health problem in Central 
and South America ( Biolo et al 2010) 
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Among the different aetiologies, chagasic cardiopathy appears to carry the worst prognosis 
(Pereyra et al 2008) and has become the most frequent cause of heart failure and sudden 
death, as well as the most common cause of cardioembolic stroke in Latin America. 
In Chagas-endemic areas, the main mode of transmission is through an insect vector called a 
triatomine bug that becomes infected with T. cruzi by feeding on the blood of an infected 
person or animal. During the day, triatomines hide in crevices in the walls and roofs. The 
bugs appears at night and bite the sleeping people to ingest blood, after that they defecate 
and by scratching the host favors the T. cruzi (trypomastigotes) entrance that are in the bug 
feces . Once inside the host, the trypomastigotes invade cells (amastigotes) The amastigotes 
multiply and differentiate again into trypomastigotes, which are then released into the 
bloodstream. This cycle is repeated in each newly infected cell and every time a triatomine 
bites an infected people.  
 
Fig. 1. Trypomastigote of Trypanosoma cruzi between red blood cells. 
T. cruzi can also be transmitted through blood transfusions; this form is not common 
because in endemic areas the blood control is exhaustive and in EEUU and Europe are now 
paying attention to this matter. Other modes of transmission include organ transplantation, 
accidental laboratory exposure and congenitally through the placenta. 
There are 3 stages in Chagas disease: the acute one with a local inflammatory lesion that 
appears at the site where the metacyclic trypomastigotes enter, and the parasite spreads 
throughout the host organism (Prata 2001, Umezawa et al 2000); the chronic phase in which 
the diversity and severity of the symptoms range from a mild electrocardiographic 
alteration to sudden death due to cardiac dysrhythmias, varing in different patients and in 
different regions (Storino & Milei 1994). In this disease the heart is the organ most 
commonly involved and the dysrhythmias , branch blocks and cardiac heart failure are 
symptoms of the 30% of patients that develop chagasic cardiomiopathy (Storino & Milei, 
1994; Andrade, 1999). but may evolve into the digestive forms, or both cardiac and digestive 
forms together. Between the acute and the chronic phases exists a period called the chronic 
indeterminate stage, which is generally symptomless and may last 10±20 years (Macedo 
1999; Ribero and Rocha 1998). 
Electrocardiographic studies give important information about aspects of cardiac function 
and are a useful tool for measuring the severity of this and others cardiopathies and also 
helps in the prognosis. 
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During the clinical course of Chagas disease electrocardiographic alterations are usually the 
first clinical evidence of disease progression, but the onset of this abnormality is rarely 
detected, since it tends to be asymptomatic at the beginning and heart involvement is 
usually clinically detected in the chronic phase. 
The normality or abnormality of the ECG in a chagasic patient is one of the factors that is 
used to determine the evolution and risk of the cardiopathy (Cuneo et al 1989). 
The first human patient infected with T. cruzi to be identified by Carlos Chagas' died of 
apparently unrelated causes when she was an adult. She had no cardiac, digestive or other 
clinical manifestations of the disease, and thus constitutes one of the best examples of the 
indeterminate stage of this disease. This form is seen in 60-70% of chronic patients, and 2-5% 
of patients in the indeterminate phase convert to a cardiac or digestive form each year, for 
reasons that are not yet clear (Umezawa et al 2000) 
This form was thought to be symptomless, but more sensitive tests have demonstrated that 
patients in this stage may present significant abnormalities (Ribeiro and Rocha 1998). 
According to cardiologists, this period is the most important to study because could be key 
in knowing which patient develops the cardiac form of infection (Elizari 1999). 
This variable progression from a clinically silent period to another more severe phase is 
probably the consequence of many factors. One of these could be parasite strain, as it has 
been suggested that genetically different stocks may produce different clinical symptoms 
(Miles et al 1981; Montamat et al 1996).Another possible factors are the health of the host 
and the possible exposure to re-infections (Prata 2001; Revelli et al 1990; Bustamante et al 
2002; 2003; 2004; 2005; 2007). 
The cardiac chronic form is the most expressive manifestation of Chagas disease, both because 
of its frequency and because of its severity. It generally appears between the second and fourth 
decades of life, 5–15 years after the initial infection. The most common signs and symptoms of 
chronic Chagas cardiopathy are arrhythmia, cardiac failure, atrioventricular and branch 
blocks, and thromboembolism (Coura 2007). The chronic chagasic cardiomyopathy is an often 
fatal outcome of this infection, with a worse prognosis than other cardiomyopathies (Bestetti 
and Muccillo, 1997; Freitas et al 2005). A diffuse myocarditis, intense myocardial hypertrophy, 
damage and fibrosis, in the presence of very few circulating T. cruzi forms, are the 
histopathological hallmarks (Higuchi et al 1987). It is also common to find dilatation of the 
cavities, with the presence of thrombi, fibrosis, and thinning of the ventricular apices, 
particularly in the left ventricle (Coura 2007). Serious alterations in the sympathetic and 
parasympathetic nervous systems have also been described (Sterin-Borda and Borda, 1994).  
Different researches demonstrates that Chagas’ disease continues to be a major cause of 
heart failure from Mexico to all South America (Capps and Abad 2004; Rigou et al 2001). 
Besides Chagas disease also represents an increasing challenge for clinicians in the United 
States (Bern et al 2007) and some European countries (Reesink 2005) due to the continuous 
immigration of people from disease-endemic countries (Polo Romero et al 2011)  
The entrance of the parasite in the target cells provokes a focal mononuclear inflammation 
and the cell lysis (Andrade, 1999; Texeira et al., 2006); these pathological lesions are detected 
in every chagasic patient, present in the heart of 94.5% of the deaths, and directly related to 
the persistence of the parasite and the pathogenesis of the disease (Texeira et al., 2006). 
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The development of different diagnostic methods with great capacity to evaluate anatomy 
and cardiac functions-multi planal echodopplercardiography, scintigraphy and 
radioisotopic angiography-or to identify in long registers the presence of arrhythmias 
dynamic electrocardiography can create the impression that conventional 
electrocardiography (ECG) might be an exam of secondary importance for chagasic patients. 
But today the ECG is still of great value due to its simplicity to do it by a medical doctor or a 
technician , low cost and its high sensitivity in detecting, most of the manifestations of 
chagasic cardiopathy (Garzon et al 1995). Having in mind the epidemiology and distribution 
of chagasic or potential chagasic patients the use of a simple technology is absolutely 
relevant. 
It has great epidemiological value and is the method of choice in longitudinal population 
studies in endemic areas; besides the advantages mentioned, its register does not require 
great qualification or training of the operator. It is known that in the natural history of 
Chagas disease, the precocity and prevalence of electrocardiographic alterations are related 
to the survival curves. For all of these reasons it has great diagnostic value. 
2. Electrocardiogram in the acute phase of Chagas disease 
The acute phase of Chagas' disease is the consequence of a generalized infection by T. cruzi, 
and is characterized by the finding of the parasite in the peripheral blood. It generally takes 
a benign course with fever and the symptoms are compatible with other pathologies. The 
mortality of 5% and 10% described in this phase is due to myocarditis or 
meningoencephallitis, and occurs mainly in the first years of life (Garzon et al 1995). 
The myocarditis can show variable severity; it may present only with tachycardia or as 
cardiac insufficiency and hypotension.  
The ECG are normal in 63% of the acute cases (Porto 1964). Sometimes it can show transitory 
alterations: the most frequent findings are non-specific and common to any myocarditis such 
as: sinus tachycardia and primary alteration of the ventricular repolarization , low QRS 
voltage, left ventricular overload and atrioventricular block of first degree. 
If the acute chagasic infection goes on with a severe myocarditis, atrioventricular blocks and 
bundle-branch block can appear. Electrocardiographic characteristics such as inactive areas, 
ST segment changes, complex ventricular arrhythmia and atrial fibrillation indicate a worse 
prognosis. The compromise of the ECG in the acute phase could be indicative of the late 
prognosis of the disease. 
Many authors (Macedo 1999; Rassi et al. 2000; Bustamante et al. 2007; Elizari 1999; Storino 
and Milei 1994) propose that among patients with a normal ECG in this phase only 30% will 
have an altered electrocardiogram in the chronic phases; this is the average of infected 
people that will develop the cardiopathy ; on the other hand, among those showing some 
abnormality, 60.9% will show an altered ECG. After the clinical symptoms disappear in the 
acute phase the electrocardiographic alterations do the same.  
One year later 75% of the cases show a normal ECG. Some (10%-20%) alternate normal 
tracings and abnormal tracings with intermittent first degree atrioventricular block and 
alteration of the ventricular repolarization. 
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3. Electrocardiogram in the chronic indeterminate phase of Chagas disease 
A positive serological reactions for T. cruzi, a normal thoracic radiography and a normal 
electrocardiographic tracing are the elements used for the characterization of the chronic 
indeterminate form of Chagas' disease. This electrocardiographic normality varies in diverse 
endemic regions: 83% in Argentina (Rigou et al 2001) 91.6% in the Brazilian state of Rio 
Grande do SuI and 68% in the state of Goias (Garzon et al 1995). It is more common in the 
first 20 years after the acute form, with the posterior appearance of some type of 
electrocardiographic alteration at a frequency of 2% to 5% per year. 
But the study of this silent and long period of the disease, with more sensitive diagnostic 
methods, either invasive or non-invasive, demonstrates that most chagasic patients with 
normal ECG have some type of anatomical or functional alteration. 
Between 10 and 20 % of patients in the chronic indeterminate stage present 
electrocardiographic alterations, almost 40% of them show abnormal echocardiogram and 
Doppler studies, such as alterations in ventricular relaxation were found in 27.6%, 
enlargement of cavities in 31%, both phenomena in 31% and alteration of the parietal 
motility in 10.3%.(Rigau et al 2001).  
Carrasco et al. 1982, followed up patients for 12 year showing that 100% of them survived 
this time when they belong to the group with normal ECG, or with minor ventriculographic 
alterations, against only 42% of the group with abnormal ECG without cardiac insufficiency. 
Other authors (Garzon et al. 1993) studied 109 seropositives patients with normal ECG , 91% 
of them presented normal left ventricular ejection fractions, but 43.1 % showed some 
abnormalities on the cineangiography of the left ventricle. 
Table 1 summarizes the most frequent findings on electrocardiograms from 1010 patients 
with positive serology , in the chronic indeterminate phase of Chagas disease, and that were 
analyzed by cineangioventriculography or other clinical and hemodynamic-
cineangiocardiographic evaluation, 
 
 Nº of cases Age 
minor left ventricle 
ejection fraction (%) 
Abnormal left 
ventricle(%) 
Normal ECG 109 39.3 ± 9.1 8.5 43 
Ventricular 
extrasystoles 
40 47.5± 9.9 50 20 
Right branch block 39 46.1± 13 23.1 30.8 
Left anterior 
hemiblock 
18 45.3± 9.8 33.3 27.8 
Anteroseptal fibrosis 5 58.5 ±12 60 20 
Table 1. Isolated findings on the electrocardiogram of 1010 chagasic patients submitted to 
cineangioventriculography or other clinical and hemodynamic evaluation (Garzon et al 1995). 
According with Manzullo et al. 2001, in endemic areas, the right branch block is a strong 
indicator for probable Chagas etiology, with a probability of 7 to 1 for this disease. 
However, among 902 young men they have studied, they detected 19 right branch block 
from which 13 had not positive Chagas serology, and must be necessarily attributed to other 
causes (Manzullo et al. 2001). 
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It is important to conclude that in chagasic patients that are coursing this long and generally 
asymptomatic period of the disease a normal ECG does not mean absence of functional or 
anatomical alterations, but all the authors agree that a normal ECG in chagasic patients, 
symptomatic or not, even coinciding with anatomical or functional alterations indicates a 
favorable prognosis with less myocardial dysfunction, than in patients with isolated ECG 
alterations (Garzon et al.1995; Manzullo and Chuit 1999)  
4. Electrocardiogram in the chronic phase of Chagas disease 
The cardiac chronic form is the most expressive manifestation of Chagas disease, both 
because of its frequency and because of its severity. It generally appears between the second 
and fourth decades of life, 5–15 years after the initial infection. The most common signs and 
symptoms of chronic Chagas cardiopathy are arrhythmia, cardiac failure, atrioventricular 
and branch blocks, and thromboembolism (Coura, 2007). The chronic chagasic 
cardiomyopathy is an often fatal outcome of this infection, with a worse prognosis than 
other cardiomyopathies (Bestetti and Muccillo, 1997; Freitas et al. 2005). A diffuse 
myocarditis, intense myocardial hypertrophy, damage and fibrosis, in the presence of very 
few circulating T. cruzi forms, are the histopathological hallmarks (Higuchi et al. 1987). It is 
also common to find dilatation of the cavities, with the presence of thrombi, fibrosis, and 
thinning of the ventricular apices, particularly in the left ventricle (Coura, 2007). Serious 
alterations in the sympathetic and parasympathetic nervous systems have also been 
described (Sterin-Borda and Borda, 1994; Lo Presti et al 2009). 
The prevalence of abnormal ECG is described by some authors (Garzon et al. 1995; 
Manzullo et al. 1995) as 4.3 times greater in seropositive men than in seronegative men, 
while seropositive women are 2.6 times greater. This means that an important number of 
patients do not have ECG alterations in the chronic phase of Chagas disease and these are 
the patients with low risk of death (Manzullo et al. 1995; Rassi et al. 1995) showing that the 
electrocardiographical studies done periodically are a good prediction indicator of evolution 
of the cardiac disease. 
Table 2 shows a mean of the findings of different authors as the most frequent 
electrocardiographic abnormalities found in the chronic phase from different regions 
(Garzon et al. 1995; Manzullo and Chuit 1999; Prata et al. 1993) 
 
Ventricular extrasystoles 40% 
Right branch block 35% 
Left anterior hemiblock 31% 
Left branch block 5% 
Alterations of the ST-T segment 27% 
Low voltage of the QRS 5% 
First degree auricular-ventricular block 3% 
Ventricular tachycardia 8% 
Atrial fibrillation 10% 
Anteroseptal fibrosis; 10% 
Presence of inactive electrical area. 15% 
Table 2. Mean of the findings of different authors as the most frequent electrocardiographic 
abnormalities found in the chronic phase from different regions. 
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If the analysis is done over dead people by Chagas disease 100% of them presented 
cardiomegaly and abnormal ECG. The most frequent ECG abnormalities are summarized in 
Table 3 ( Manzullo and Chuit 1999; Garzon et al 1995) 
 
Right bundle branch block 96.8% 
Repolarization primary alterations 80% 
Areas of inactivation 72% 
Polifocal ventricular arrithmia 100% 
Table 3. Most frequent ECG abnormalities in patients dead by cardiac insufficiency 
provoked by Chagas disease. 
In the study of 5710 patients carried out by Manzullo and Chuit (1999), they also analyzed 
the ECG alterations in 15 people that died by sudden death with chagasic cardiopathy. Their 
results showed that only 1 patient presented normal ECG, 1 with indication of pace maker 
and the last 13 presented associated the following ECG alterations: right bundle branch 
block, left anterior hemiblock, repolarization primary alterations, ventricular inactivated 
areas, ventricular arrithmia. 
The Argentinean people with an age between 20 and 60 years die 2.6 per/1000 yearly while 
chagasic people of the same age die 4 per/1000, demonstrating that chagasic patient have 
53. % higher risk of death than the rest of the population. 
5. Experimental model for Chagas disease 
The mice model for Chagas’ disease was described by Laguens et al. (1980), from a 
pathological, immunological and electrocardiographic point of view, demonstrating that 
they reproduce in a short time the three phases of Chagas disease in a similar manner that in 
patients. The vantages is that 10 to 30 year are reduced to 365 days; in one year post 
infection this experimental model reproduces the chronic chagasic cardiopathy allowing 
studies that produce findings to understand the pathophysiology of the disease and 
consequently the prevention of it. Mover, electrophysiology of normal mice and infected 
mice have been profusely reviewed (Berut et al. 1996; Wehrens et al. 2000) and have been 
largely studied in our lab ( Bustamante et al. 2004; 2005; Lo Presti et al. 2006; 2008; 2009) . 
6. Electrocardiograms in the experimental model 
Electrocardiogram (ECG) tracings can be obtained with a digital electrocardiographic unit or 
any other electrocardiographic unit, under Ketamine CLH, anaesthesia (10 mg/kg). 
Electrocardiographic recording of non infected and infected with T. cruzi mice are obtained 
under anesthesia. The electrocardiographic tracings can be obtained with 6 standard leads 
(contact electrode) (dipolar leads DI, DII, DIII and unipolar leads aVR, aVL, aVF), as shows 
Figure 2 , recording at 50 mm/s with amplitude set to give 1 mV/10 mm. The 
electrocardiographic parameters analysed are: cardiac frequency, length of the PR segment 
and duration of the Q-T interval. Data were then transferred to a computer for further 
analysis. Wave durations (in sec) can be calculated automatically by the software 
(CardioCom) after cursor placement or can be read by the operator as usually. 
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Fig. 2. Mouse placed for the ECG recording under Kethamine CLH anaesthesia The mouse is 
introduced in a Faraday cage to avoid electrical interferences. 
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The main electrocardiographic alterations obtained in this experimental model are 
summarized in Table 4 and were: modifications in auricle–ventricle conduction 
(prolonged PQ segment) and in intraventricular conduction (prolonged QRS complex), 
alteration in auricle–ventricle conduction associated to intraventricular conduction and 
arrhythmia. Results shown in Table 4 were obtained from several works carried out in our 
lab (Rivarola et al. 1999; 2001; Bustamante et al. 2002; Rivarola and Paglini-Oliva 
2002;Bustamante et al. 2003) 
Figure 3 shows the electrocardiographic alterations provoked by the infection of mice with 
two different T cuzi strain: Tulahuen strain (Taliafero and Pizzi 1955) and with the SGO Z12 
isolate (Montamat et al. 1996; Bustamante et al 2003). This isolate was obtained from a 
chronic patient who lived in an endemic area of Argentina and it was demonstrated, 
through its electrophoretic pattern (Montamat et al. 1996), that it belongs to zymodeme 12 
from Argentina (Bustamante et al 2003 ). 
 
 
 
 
 Uninfected 
Infected 
(35 dpi, 
acute phase) 
Infected 
(75 dpi,chronic 
indeterminate 
phase 
Infected 
(135 dpi,early 
chronic phase) 
Infected 
(365 dpi, 
late chronic 
phase) 
Mean(SE)pulse 
rate (beats/m) 
446(13.5) 468 (12.1) 575 (4.8) 526(16.9) 646.19(22.08) 
Mean(SE)axes 
(grades) 
66 (4.7) 51(4.7) 44(2.3) 55(2.9) 57(3) 
PQ intervals (s) 0.02 0.02-0.04 0.03-0.04 0.02-0.05 0.02-0.05 
QRS intervals (s) 0.02-0.03 0.02-0.03 0.02-0.04 0.02-0.06 0.02-0.06 
% of mice  
showing some 
ECG abnormalities 
2 12.5 60 66 60 
 
Dpi : days post infection. Mean (SE) 
 
Table 4. Mean results of the electrocardiographic studies carried out in 100 uninfected mice 
and in 100 mice during the acute, chronic indeterminate and chronic stage of the T. cruzi 
infection. 
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Fig. 3. Electrocardiograms in DIII dipolar lead obtained from: (A) uninfected mice showing 
no electrocardiographic alterations; (B) Tulahuen strain infected mice 75 days p.i.(post-
infection) with no conductive alterations (50% of the mice); (C) Tulahuen strain-infected 
mice 75 days p.i. showing intra-ventricular blockade (IVB) (arrows) (19% of the mice from 
this group); (D) SGO-Z12 isolate-infected mice 90 days p.i. with no electrocardiographic 
alterations (65% of the mice); (E) SGO-Z12 isolate-infected mice 90 days p.i. showing 
auricle–ventricle blockade (AVB) (arrows) (19% of the mice); (F) SGO-Z12 isolate infected 
mice 90 days p.i. showing IVB associated with AVB (arrows) (8% of the mice); (G) Tulahuen 
strain-infected mice 135 days p.i. (cardiac chronic phase) showing IVB associated with AVB 
(arrows) (38% of the mice); (H) SGO-Z12 isolate-infected mice 135 days p.i. (cardiac chronic 
phase) showing IVB associated with AVB (arrows) (56% of the mice). 
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There is another important aspect to analyze in endemic countries for Chagas disease and is 
that people living in endemic areas are exposed not only to infections but also to reinfections 
at any time, therefore we concentrated our efforts on studying this factor as a matter that 
increases the electrocardiographic abnormalities and the severity of the cardiac damage 
(Bustamante et al . 2002; 2003; 2004; 2005). 
Figure 4 shows the importance of the reinfections to increase the number of ECG 
abnormalities found in infected mice.  
 
 
 
 
 
 
 
Fig. 4. Evolution of the percentages of non-infected (▲ , infected without reinfections (○), 
acutely reinfected with 50 trypomastigotes (□) or with 500 trypomastigotes (■) and 
chronically reinfected (●) mice showing at least 1 kind of electrocardiographic abnormality 
along the 3 phases of experimental Chagas’ disease. Dark arrows indicate acute reinfection 
time and white arrow indicates chronic reinfection time. *P<0.01 when compared between 
groups at the same time. 
Table 5 shows the most important ECG alterations found in the reinfected models along the 
evolution of the chagasic infection in a long term study of 450 days post infection 
(Bustamante et al. 2004). 
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Groups 
Auricle–ventricle 
blockade 
(prolonged PQ 
segment) 
IVB: 
intraventricular 
blockade (prolonged 
QRS complex) 
Auricle-venticular 
blockade associated 
with intraventricular 
Arrhythmias 
30 dpi     
Infected n:32 9.4 3.1 NF NF 
Reinfected in the 
acute satage n:21 
61.9 NF 9.5 9.5 
Reinfected in the 
chronic stage n:18 
11.1 38.9 16.5 5 
Non Infected n:50 2 NF NF 4 
60 dpi     
Infected n:15 46.7 NF 20 NF 
Reinfected in the 
acute satage n:14 
50 14.3 7 14.3 
Reinfected in the 
chronic stage n:15 
15.4 30.8 23.1 7.7 
Non Infected n: 50 2 NF NF 4.3 
90 dpi     
Infected n:15 26.7 13.3 NF 13.3 
Reinfected in the 
acute satage n:9 
67 NF 33.3 NF 
Reinfected in the 
chronic stage n:9 
71.4 NF 28.6 NF 
Non Infected n:50 2 NF NF 4 
360 dpi     
Infected n:29 48.3 3.4 6.9 6.9 
Reinfected in the 
chronic stage n:29 
65 5 20 4 
Non Infected n:50 2 NF NF 10 
390 dpi     
Infected n:30 50 NF 10 10 
Reinfected in the 
chronic stage n:30 
65 5 20 10 
Non Infected n:50 2 NF NF 4 
420 dpi     
Infected n:24 40 NF 15 15 
Reinfected in the 
chronic stage n:30 
90 NF 8 5 
Non Infected n:50 2 NF NF 4 
450 dpi     
Infected n:24 50 NF NF 20 
Reinfected in the 
chronic stage n:24 
91.6 NF 8.4 NF 
Non Infected n:50 2 NF NF 4 
NF: not found 
Table 5. Percentage of the most frequent ECG alterations in infected and reinfected with  
T. cuzi mice. 
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Results shown in the previous Table demonstrate that when the host is reinfected in the 
acute phase of experimental Chagas’disease, present significantly more serious 
electrocardiographic alterations than those developed when the reinfections occur in the 
chronic stage. Reinfections increased the number of electrocardiographic abnormalities 
Thus sudden death described in some chagasic patients, might be related to some of these 
results. 
7. Final considerations 
Chagas disease affects nearly 16 million people in Latin America and causes 75 to 90 million 
people to be at risk of infection predominantly in poor regions of Latin America. This 
disease is also urbanizing and globalizing due to frequent migrations. The 
electrocardiogram is one of the best and easy way to measure and diagnose Chagas disease. 
Because of its low cost, easy use and interpretation, it has epidemiological value in endemic 
areas with difficulties to get access to more sensitive diagnosis methods. 
The prevalence of certain alterations such as right bundle branch block associate with left 
bundle branch and/or ventricular extrasystoles with a positive serological reaction are very 
simple methods and available any where to make a clear diagnosis of Chagas disease. More 
sensitive diagnostic methods that allow a better evaluation of the structure and cardiac 
functions and many different professionals dedicated to the study of Chagas disease from 
different points of views, have significantly increased the knowledge of this cardiopathy. 
But the correlation of these findings with characteristics ECG alterations has made this 
simple method of great valuable to follow patients and make a prognosis of the evolution of 
the chagasic cardiopathy. 
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